Hexo Corp. (NYSE:HEXO) has fallen substantially since my article in August 2019 on the stock. HEXO stock has lost over $700 million in market value in that period, falling from $1.1 billion to $360 million over that period. Source: Shutterstock That’s the sign of a loser stock and unimaginative management that don’t understand how markets
admin
Yet, through a reverse merger with special purpose acquisition company (SPAC) Social Capital Hedosophia Holdings II (NYSE:IPOB), traders can now take a stake in Opendoor through a long position in IPOB stock. Source: Shutterstock Real estate, reinvented. That’s what real estate technology services firm Opendoor envisions for the future, but it wasn’t tradable until recently. I
Less than two months into life as a public company, Palantir Technologies (NYSE:PLTR) is proving investors love the shiny new object when it comes to data infrastructure and technology fare. PLTR stock is already up nearly 68% since its Sept. 30 initial public offering (IPO). Source: Sundry Photography / Shutterstock.com Colorado-based Palantir is classified as
Jay Clayton, who has led the Securities and Exchange Commission for the past three and a half years that included a number of major changes in financial markets, said Monday he will step down at the end of the year. “Working alongside the incredibly talented and driven women and men of the SEC has been
Traders work the floor of the New York Stock Exchange. NYSE FANG may be lagging, but don’t count technology stocks out. Positive news on vaccines has spurred buying in cyclical stocks that should do well when the economy is running at full speed again. Last week, tech stocks, and high-flying FANG names, sold off after
If you have an asset, you can probably get a loan against it. Your paycheck, your tax return, your home, your 401(k), and, yes, even your pension if you’re one of the relatively few people who still have one. If you’ve never heard of a pension advance, consider yourself lucky. They’re also called pension sales,
I’ll admit to knowing nothing about Ever-Glory International (NASDAQ:EVK), a China-based apparel manufacturer and retailer, before I conducted research for this column. But I knew there had to be something about EVK stock that was drawing the attention of our readers. A quick glance shows some significant price action and a surge of trading volume
Macroeconomic conditions typically affect industries in different ways. But whenever an economic decline occurs, shares of businesses operating in cyclical sectors get adversely affected. This year’s pandemic has pushed many economies around the world close to a recession. But in November, hopes of a coronavirus vaccine drove greater positive investor sentiment. Today we will take
I will start with the conclusion, then work backwards into it. Investors can own Southwest (NYSE:LUV) stock for the long haul recovery. Shorter term, I would prefer to buy it on the dip towards $40. Last week’s Pfizer (NYSE:PFE) headline spike placed resistance above, so it will be a slog for a few weeks. Case
Gregg Lemkau, co-head of investment banking for Goldman Sachs & Co. Christopher Goodney | Bloomberg | Getty Images Goldman Sachs is losing one of its top dealmakers. Gregg Lemkau, a nearly-three decade veteran of the bank and co-head of its powerhouse investment banking division, is leaving Goldman at the end of the year, according to
People walk by a T-Mobile store in San Francisco, California Justin Sullivan | Getty Images Check out the companies making headlines after the bell on Monday: T-Mobile — T-Mobile shares rose more than 2% in after-hours trading after Warren Buffett’s Berkshire Hathaway disclosed a stake in the mobile networking company. A 13F filing showed the
Despite stocks plunging and high volatility in the market, 2020 has also seen continued growth within the exchange traded fund (ETF) market. The top five issuers of ETFs alone each have $100 billion or more in assets under management (AUM). In addition to overall growth, there have been other new developments and trends in the
Every major sector has felt the wrath of the novel coronavirus pandemic. However, some industries have completely buckled under pressure — in particular, oil and gas. Oil stocks are a major casualty of the current crisis, and it’s hard to find a name that is not currently flat or down on the year as of
In July 2020, McKinsey indicated that 250 vaccine candidates are being pursued globally. The consulting firm also estimated that between five to seven vaccines would be approved in the next two years. Inovio Pharmaceuticals (NASDAQ:INO) has been in the race for the vaccine against Covid-19 and INO stock has exhibited high volatility. Source: Ascannio /
It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. I thought NextEra Energy stock was a buy. Source: madamF / Shutterstock.com And I still do. Here’s why. Renewable Energy Is Not Going Away Before I get
Somehow, it just feels odd to write an analysis of a company with the mighty seafarin’ name of Ocean Power Technologies (NASDAQ:OPTT) when its OPTT stock has a price befitting a kiddie pool: $1.67 per share. This, as you may well know, is penny stock territory and tossing pennies in a fountain (or the “Ocean”
Canopy Growth Corp. (NYSE: CGC; TSX: WEED) is a Canada-based holding company that produces, distributes, and sells a variety of cannabis and hemp-based products for medical and recreational use. Its products include dried flower, hemp, vape pens and cartridges, THC- and CBD-infused beverages, and edibles. Founded in 2013, Canopy Growth faces competition from a large
Some stories — you know, crazy pandemics, crazier elections, craziest wardrobe fails — make so many headlines these days that they’ve shoved otherwise major developments off to the side. One of those, 5G technology, promises to change mobile communications like nothing else in generations. Vying for a nice slice of the pie is Nokia (NYSE:NOK),
When looking at the best entertainment stocks to buy, investors are realizing that upcoming holiday season is unlikely to be the same as the previous years. Another wave of coronavirus infections would imply that consumers are more cautious. However, in the last two months, U.S. consumer confidence has improved and this will translate into higher
When I last wrote about Sorrento Therapeutics (NASDAQ:SRNE) in early October, it was trading around $11.20, well down from its all-time high of $19.39, still up significantly from where it started the year. Source: Shutterstock At the time, I suggested that Sorrento was a better buy in the single digits. Now trading around $6 as